176 related articles for article (PubMed ID: 25217328)
1. Effect of plasma exchange and immunosuppressive medications on antibody titers and outcome in anti-complement factor H antibody-associated hemolytic uremic syndrome.
Khandelwal P; Gupta A; Sinha A; Saini S; Hari P; Dragon Durey MA; Bagga A
Pediatr Nephrol; 2015 Mar; 30(3):451-7. PubMed ID: 25217328
[TBL] [Abstract][Full Text] [Related]
2. Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children.
Sinha A; Gulati A; Saini S; Blanc C; Gupta A; Gurjar BS; Saini H; Kotresh ST; Ali U; Bhatia D; Ohri A; Kumar M; Agarwal I; Gulati S; Anand K; Vijayakumar M; Sinha R; Sethi S; Salmona M; George A; Bal V; Singh G; Dinda AK; Hari P; Rath S; Dragon-Durey MA; Bagga A;
Kidney Int; 2014 May; 85(5):1151-60. PubMed ID: 24088957
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of renal transplant in patients with anti-complement factor H antibody-associated hemolytic uremic syndrome.
Khandelwal P; Sinha A; Hari P; Bansal VK; Dinda AK; Bagga A
Pediatr Transplant; 2014 Aug; 18(5):E134-9. PubMed ID: 24814615
[TBL] [Abstract][Full Text] [Related]
4. Pulse cyclophosphamide therapy and clinical remission in atypical hemolytic uremic syndrome with anti-complement factor H autoantibodies.
Boyer O; Balzamo E; Charbit M; Biebuyck-Gougé N; Salomon R; Dragon-Durey MA; Frémeaux-Bacchi V; Niaudet P
Am J Kidney Dis; 2010 May; 55(5):923-7. PubMed ID: 20202729
[TBL] [Abstract][Full Text] [Related]
5. Long-term remission of atypical HUS with anti-factor H antibodies after cyclophosphamide pulses.
Sana G; Dragon-Durey MA; Charbit M; Bouchireb K; Rousset-Rouvière C; Bérard E; Salomon R; Frémeaux-Bacchi V; Niaudet P; Boyer O
Pediatr Nephrol; 2014 Jan; 29(1):75-83. PubMed ID: 23868108
[TBL] [Abstract][Full Text] [Related]
6. The clinical and laboratory features of Chinese Han anti-factor H autoantibody-associated hemolytic uremic syndrome.
Song D; Liu XR; Chen Z; Xiao HJ; Ding J; Sun SZ; Liu HY; Guo WY; Wang SX; Yu F; Zhao MH;
Pediatr Nephrol; 2017 May; 32(5):811-822. PubMed ID: 28035470
[TBL] [Abstract][Full Text] [Related]
7. Abbreviated protocol of plasma exchanges for patients with anti-factor H associated hemolytic uremic syndrome.
Thangaraju S; Khandelwal P; Mishra K; Kumar M; Puraswani M; Saini R; Hari P; Coshic P; Sinha A; Bagga A
Pediatr Nephrol; 2024 Jul; 39(7):2091-2097. PubMed ID: 38270601
[TBL] [Abstract][Full Text] [Related]
8. Rituximab to Abbreviate Plasma Exchange in Anti-CFH (Complement Factor H) Antibody Mediated Atypical HUS.
Mittal A; Dijoo M; Aggarwal S; Gulati S
Iran J Kidney Dis; 2019 Mar; 13(2):134-138. PubMed ID: 30988252
[TBL] [Abstract][Full Text] [Related]
9. Clinical and Immunological Profile of Anti-factor H Antibody Associated Atypical Hemolytic Uremic Syndrome: A Nationwide Database.
Puraswani M; Khandelwal P; Saini H; Saini S; Gurjar BS; Sinha A; Shende RP; Maiti TK; Singh AK; Kanga U; Ali U; Agarwal I; Anand K; Prasad N; Rajendran P; Sinha R; Vasudevan A; Saxena A; Agarwal S; Hari P; Sahu A; Rath S; Bagga A
Front Immunol; 2019; 10():1282. PubMed ID: 31231391
[No Abstract] [Full Text] [Related]
10. Successful discontinuation of eculizumab under immunosuppressive therapy in DEAP-HUS.
Hackl A; Ehren R; Kirschfink M; Zipfel PF; Beck BB; Weber LT; Habbig S
Pediatr Nephrol; 2017 Jun; 32(6):1081-1087. PubMed ID: 28220235
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of DEAP-HUS with eculizumab.
Noone D; Waters A; Pluthero FG; Geary DF; Kirschfink M; Zipfel PF; Licht C
Pediatr Nephrol; 2014 May; 29(5):841-51. PubMed ID: 24249282
[TBL] [Abstract][Full Text] [Related]
12. Successful renal transplantation in factor H autoantibody associated HUS with CFHR1 and 3 deficiency and CFH variant G2850T.
Waters AM; Pappworth I; Marchbank K; Bockenhauer D; Tullus K; Pickering MC; Strain L; Sebire N; Shroff R; Marks SD; Goodship TH; Rees L
Am J Transplant; 2010 Jan; 10(1):168-72. PubMed ID: 19951285
[TBL] [Abstract][Full Text] [Related]
13. Clinical features of children with anti-CFH autoantibody-associated hemolytic uremic syndrome: a report of 8 cases.
Li Q; Kong X; Tian M; Wang J; Yang Z; Yu L; Liu S; Wang C; Wang X; Sun S
Ren Fail; 2022 Dec; 44(1):1061-1069. PubMed ID: 35730179
[TBL] [Abstract][Full Text] [Related]
14. Early relapse rate determines further relapse risk: results of a 5-year follow-up study on pediatric CFH-Ab HUS.
Hofer J; Riedl Khursigara M; Perl M; Giner T; Rosales A; Cortina G; Waldegger S; Jungraithmayr T; Würzner R
Pediatr Nephrol; 2021 Apr; 36(4):917-925. PubMed ID: 33025207
[TBL] [Abstract][Full Text] [Related]
15. [Clinical characteristies of atypical hemolytie uremic syndrome associated with H factor antibody in children].
Guan N; Liu X; Yao Y; Yang J; Wang F; Xiao H; Ding J; Zhao M; Yu F; Wang F
Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):223-6. PubMed ID: 24824395
[TBL] [Abstract][Full Text] [Related]
16. Complement factor H-related protein 1 deficiency and factor H antibodies in pediatric patients with atypical hemolytic uremic syndrome.
Hofer J; Janecke AR; Zimmerhackl LB; Riedl M; Rosales A; Giner T; Cortina G; Haindl CJ; Petzelberger B; Pawlik M; Jeller V; Vester U; Gadner B; van Husen M; Moritz ML; Würzner R; Jungraithmayr T;
Clin J Am Soc Nephrol; 2013 Mar; 8(3):407-15. PubMed ID: 23243267
[TBL] [Abstract][Full Text] [Related]
17. The autoimmune disease DEAP-hemolytic uremic syndrome.
Skerka C; Zipfel PF; Müller D; Micklisch S; Riedl M; Zimmerhackl LB; Hofer J
Semin Thromb Hemost; 2010 Sep; 36(6):625-32. PubMed ID: 20865639
[TBL] [Abstract][Full Text] [Related]
18. Factor H autoantibody is associated with atypical hemolytic uremic syndrome in children in the United Kingdom and Ireland.
Brocklebank V; Johnson S; Sheerin TP; Marks SD; Gilbert RD; Tyerman K; Kinoshita M; Awan A; Kaur A; Webb N; Hegde S; Finlay E; Fitzpatrick M; Walsh PR; Wong EKS; Booth C; Kerecuk L; Salama AD; Almond M; Inward C; Goodship TH; Sheerin NS; Marchbank KJ; Kavanagh D
Kidney Int; 2017 Nov; 92(5):1261-1271. PubMed ID: 28750931
[TBL] [Abstract][Full Text] [Related]
19. Plasma exchanges and immunosuppression for anti-complement factor H associated hemolytic uremic syndrome.
Khandelwal P; Sinha A; Hari P; Bagga A
Indian Pediatr; 2014 Oct; 51(10):833-5. PubMed ID: 25362019
[TBL] [Abstract][Full Text] [Related]
20. Use of eculizumab and plasma exchange in successful combined liver-kidney transplantation in a case of atypical HUS associated with complement factor H mutation.
Tran H; Chaudhuri A; Concepcion W; Grimm PC
Pediatr Nephrol; 2014 Mar; 29(3):477-80. PubMed ID: 24221349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
